Latest Lymphocytic Leukemia Stories
A new protein-based treatment could help treat acute lymphoblastic leukemia (ALL) patients whose cancer cells have developed resistance to contemporary chemotherapy, according to new research published online Monday in the Journal of Clinical Investigation.
WHITE PLAINS, N.Y., Jan. 29, 2015 /PRNewswire-USNewswire/ -- Today's U.S.
The leukemia therapeutics market report gives the detailed analysis on the major market drivers, restraints, and opportunities in North America, & Europe.
New IMBRUVICA Data from National Institutes of Health Study Published in The Lancet Oncology SUNNYVALE, Calif., Jan. 5, 2015 /PRNewswire/ -- Pharmacyclics, Inc.
SUNNYVALE, Calif., Dec. 22, 2014 /PRNewswire/ -- Pharmacyclics, Inc.
SUNNYVALE, Calif., Dec.
IMBRUVICA data presented at the American Society of Hematology Annual Meeting show 79 percent of CLL patients with del 17p were progression-free at 12 months SAN FRANCISCO and RARITAN, N.J.,
Data Show 84% Progression-Free Survival Rate at One Year and Improvement in Quality of Life SAN FRANCISCO, Dec. 8, 2014 /PRNewswire/ -- Pharmacyclics, Inc.
Secondary Analysis Demonstrates 40 Percent of Patients who Achieved Complete Remission Were Enabled to Proceed to Stem Cell Transplant THOUSAND OAKS, Calif., Dec.
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.